SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gwolf who wrote (1323)	6/18/1998 10:24:00 PM
From: chirodoc	of 5402

MORE PROOF THAT THIS IS SAFE AND EFFECTIVE........ EVEN THE OLD, OLD VERSION!!!! ,,,note that this was 14 years ago before the 2nd and 3rd generation concoctions were developed. Ann Plast Surg 1984 May;12(5):449-453 Fluosol-DA, a perfluorochemical oxygen-transport fluid for the management of a trochanteric pressure sore in a Jehovah's Witness. Brown AS, Reichman JH, Spence RK A 54-year-old paraplegic with a right trochanteric pressure sore was refused reconstructive surgery because of his hemoglobin count of 6 gm/dl and his refusal to accept blood transfusions because of religious beliefs. Utilization of Fluosol-DA, a perfluorochemical oxygen-transport fluid that has recently become available to us for clinical trial, enabled us to deal successfully with this man's problem despite the profound anemia, since tissue oxygen delivery was provided with arterial oxygen partial pressures as high as 500 torr after infusion. Patients previously denied operations on the basis of their blood counts and their refusal to receive blood transfusions may in the future be offered the option of an oxygen-carrying fluid such as Fluosol to allow them to safely undergo reconstructive procedures.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next